The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: Ospens

Monday Biotech Deal Review: February 1, 2010

Canadian biotech companies were busy making and closing deals this week, with $44 million raised, four new licensing and collaboration deals, and particularly big weeks for Ospens and the MDS/Dahaner transaction. Read more of this post

NRC-IRAP Is On A Roll: 7 Bio Investments in 7 Weeks

NRC-IRAP LogoNRC-IRAP,* which got $170 million in Canadian stimulus money, has been deploying funds quite rapidly and has included a significant number of biotechs in its largesse.  I found these from July and August:

Am I missing others?  Let us know in the comments.

Oh, and speaking of government money, hopefully you’ve started following the Twitter stream @crossborderbio and you saw this announcement earlier today about EDC and Brookfield’s $1 billion fund for DIP lending.

* National Research Council of Canada Industrial Research Assistance Program.  Stick to the abbreviation.

Bookmark and Share

Monday Deal Review: July 12, 2009

B&W_BigNickelThe highlights of this week were definitely the Bioniche-Endo deal and Allostera’s $17 million raise, but that was just the tip of the iceberg as Canadian deal activity heated up along with the weather.  A novel deal with an income trust swapping cash for a biotech’s public shell starts things off after the jump…

Follow

Get every new post delivered to your Inbox.

Join 126 other followers